Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.

Aghamohammadi, Mehdi; Alizargar, Javad; Hsieh, Nan-Chen; Wu, Shu-Fang Vivienne

Aghamohammadi, Mehdi; Alizargar, Javad; Hsieh, Nan-Chen; Wu, Shu-Fang Vivienne.

Aghamohammadi M; Department of Internal Medicine, Vali-e-asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Alizargar J; Research Center for Healthcare Industry Innovation, National Taipei University of Nursing and Health Sciences, Taipei City, 112, Taiwan. Electronic address: jaz.tmu@gmail.com.
Hsieh NC; Department of Information Management, National Taipei University of Nursing and Health Sciences, Taipei City, 112, Taiwan.
Wu SV; College of Nursing, School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei City, 112, Taiwan.

J Formos Med Assoc ; 119(7): 1230-1231, 2020 07.

Article en En | MEDLINE | ID: mdl-32402522

Asunto(s)

Anticoagulantes; Infecciones por Coronavirus; Pandemias; Neumonía Viral; Accidente Cerebrovascular; Betacoronavirus; COVID-19; Humanos; Italia; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Accidente Cerebrovascular / Pandemias / Anticoagulantes Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google